Breast Cancer Trial, Recruiting NCT07580105 Sponsor: Kenko Imalytics S.L. Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07580105
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women who have a suspected breast cancer diagnosis or are being monitored for breast cancer, and who have had a specific type of MRI scan (including three types of imaging sequences: perfusion, diffusion, and T2) for reasons such as staging, checking how well treatment before surgery is working, a strong suspicion of breast cancer, or routine follow-up.
  • Women having the MRI for follow-up purposes must have previous breast MRI scan data available from within the last 12 months before the screening visit.
  • Women aged 18 and older.
  • Women who are able to understand the study information and consent forms, and who are able to give their voluntary agreement to take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • Women who are pregnant.
  • People whose MRI scan results are incomplete or not usable (for example, if one of the required scan types did not work properly).
  • People for whom having an MRI scan is not safe or not possible.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +34 697 70 84 87

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kenko Imalytics S.L.
Registry
ClinicalTrials.gov
Start date
1 May 2026
Est. completion
1 May 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

The False Positive (FP), False Negatives (FN), True Positives (TP), and True Negatives (TN) rates.; Interpretation time.; The occurrence of non-serious and serious device-related, or device procedures-related adverse events, and device deficiencies.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov